Author/Editor     Trkov, Saša; Stenovec, Matjaž; Miš, Katarina; Pirkmajer, Sergej; Zorec, Robert
Title     Fingolimod suppresses the proinflammatory status of interferon-[gamma]-activated cultured rat astrocytes
Type     članek
Publication year     2019
Volume     str. str.
ISSN     0893-7648 - Molecular neurobiology
Language     eng
Abstract     Astroglia, the primary homeostatic cells of the central nervous system, play an important role in neuroinflammation. They act as facultative immunocompetent antigen-presenting cells (APCs), expressing major histocompatibility complex (MHC) class II antigens upon activation with interferon (IFN)-[gamma] and possibly other proinflammatory cytokines that are upregulated in disease states, including multiple sclerosis (MS).We characterized the anti-inflammatory effects of fingolimod (FTY720), an established drug for MS, and its phosphorylated metabolite (FTY720-P) in IFN-[gamma]-activated cultured rat astrocytes. The expression of MHC class II compartments, [beta]2 adrenergic receptor (ADR-[beta]2), and nuclear factor kappa-light-chain enhancer of activated B cells subunit p65 (NF-KB p65) was quantified in immunofluorescence images acquired by laser scanning confocal microscopy. In addition, MHC class II-enriched endocytotic vesicles were labeled by fluorescent dextran and their mobility analyzed in astrocytes subjected to different treatments. FTY720 and FTY720-P treatment significantly reduced the number of IFN-K-induced MHC class II compartments and substantially increased ADR-[beta]2 expression, which is otherwise small or absent in astrocytes in MS. These effects could be partially attributed to the observed decrease in NF-KB p65 expression, because the NF-KB signaling cascade is activated in inflammatory processes.We also found attenuated trafficking and secretion from dextran-labeled endo-/lysosomes that may hinder efficient delivery of MHC class II molecules to the plasma membrane. Our data suggest that FTY720 and FTY720-P at submicromolar concentrations mediate anti-inflammatory effects on astrocytes by suppressing their action as APCs, which may further downregulate the inflammatory process in the brain, constituting the therapeutic effect of fingolimod in MS.
Keywords     astrociti
centralni živčni sistem
interferon-gama
astrocytes
central nervous system
interferon-gamma